Cat. No. |
Name |
CAS No. |
Description |
KI0081 |
GSK690693 |
937174-76-0 |
GSK690693 is a novel ATP competitive, pan-AKT kinase inhibitor....
|
KI4701 |
GSK2334470 |
1227911-45-6 |
....
|
KI1188 |
GSK2126458 |
1086062-66-9 |
GSK2126458 is a highly potent inhibitor of PI3K and the mammalian target of rapamycin (mTOR)....
|
KI1469 |
GSK-2636771 |
1372540-25-4 |
GSK-2636771 is a PI3K p110β isoform specific inhibitor....
|
KI4165 |
GDC0941 bimesylate |
957054-33-0 |
....
|
KI0087 |
GDC0068 |
1001264-89-6 |
GDC0068 is a selective ATP-competitive Akt inhibitor....
|
KI1313 |
GDC-0980 |
1032754-93-0 |
GDC-0980 is a potent, selective and oral inhibitor of class I PI3K and mTOR kinase....
|
KI0335 |
GDC-0941 |
957054-30-7 |
GDC-0941 is a novel small-molecule inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3, 33, 3 and 75 nM, respectively....
|
KI0241 |
Everolimus (Rad001) |
159351-69-6 |
Everolimus is an inhibitor of mammalian target of rapamycin (mTOR)....
|
KI2117 |
ETP-46464 |
1345675-02-6 |
ETP-46464 is a potent inhibitor of mTOR, ATR, DNA-PK, PI 3-KΑ and ATM....
|
KI3894 |
DBeq |
177355-84-9 |
....
|
KI2568 |
CZC24832 |
1159824-67-5 |
CZC24832 is a highly selective and potent ATP-competitive PI3Kγ inhibitor....
|
KI0518 |
CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K....
|
KI0321 |
CT99021 |
252917-06-9 |
CT99021 is a GSK-3 inhibitor with IC50 of 10 and 6.7 nM for GSK-3α and GSK-3β, respectively....
|
KI3320 |
CHIR-98014 |
252935-94-7 |
CHIR-98014 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3)....
|
KI0600 |
CH5132799 |
1007207-67-1 |
CH5132799 potently and selectively inhibits PI3Kα and mTOR with IC50 values of 14 nM and 1.6 µM, respectively....
|
KI4693 |
CCT128930 |
885499-61-6 |
....
|
KI4541 |
CAY10505 |
1218777-13-9 |
....
|
KI0192 |
CAL-101 |
870281-82-6 |
CAL-101 is a potent and selective inhibitor of p110d with an IC50 of 2.5 nM....
|
KI3091 |
BYL-719 |
1217486-61-7 |
BYL-719 is a potent and selective inhibitor of PI3Kα....
|